世界のECMO装置市場規模に関する調査および予測:構成部品別(ポンプ、オキシゲネーター、コントローラー)、モダリティ別(VA、VV、AV)、患者タイプ別(成人患者、小児患者、新生児患者)、 用途(心臓補助、呼吸補助、体外式心肺蘇生(ECPR)、移植待機期間の橋渡し)、および地域別予測 2025-2035年Global ECMO Machine Market Size Study and Forecast by Component (Pumps, Oxygenator, Controllers), Modality (VA, VV, AV), Patient Type (Adult Patients, Pediatric Patients, Neonatal Patients), Application (Cardiac Support, Respiratory Support, Extracorporeal Cardiopulmonary Resuscitation (ECPR), Bridge to Transplant), and Regional Forecasts 2025-2035 Market Definition, Recent Developments & Industry Trends Extracorporeal Membrane Oxygenation (ECMO) machines are advanced life-support systems designed to provide prolonged cardiac and respiratory... もっと見る
出版社
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング 出版年月
2026年3月24日
電子版価格
納期
3-5営業日以内
ページ数
285
言語
英語
英語原文をAI翻訳して掲載しています。
サマリーMarket Definition, Recent Developments & Industry TrendsExtracorporeal Membrane Oxygenation (ECMO) machines are advanced life-support systems designed to provide prolonged cardiac and respiratory assistance to patients whose heart and lungs are unable to function adequately. The system works by circulating blood through an external artificial lung (oxygenator) and pump, facilitating gas exchange and hemodynamic support before returning it to the patientfs body. The ECMO ecosystem comprises device manufacturers, critical care units, perfusionists, cardiac surgeons, and tertiary care hospitals, primarily operating within intensive care and specialized cardiac centers. The market has evolved significantly over the past decade, driven by technological advancements in miniaturized pumps, biocompatible oxygenators, and portable ECMO systems. Increased clinical adoption during global respiratory crises and rising cases of cardiopulmonary disorders have expanded the utilization landscape. As healthcare systems invest in advanced critical care infrastructure, ECMO is increasingly positioned as both a rescue therapy and a bridge-to-transplant solution. Looking ahead to 2035, integration of digital monitoring systems, improved safety profiles, and expansion into emerging healthcare markets are expected to shape the competitive and technological trajectory of the ECMO machine industry. Key Findings of the Report - Market Size (2024): USD 0.32 billion - Estimated Market Size (2035): USD 0.58 billion - CAGR (2025-2035): 5.50% - Leading Regional Market: North America - Leading Segment: Oxygenator under Component Market Determinants Rising Incidence of Cardiopulmonary Disorders The growing prevalence of acute respiratory distress syndrome (ARDS), heart failure, and cardiogenic shock is a primary growth driver. ECMO machines provide life-saving support in critical cases, increasing their adoption in tertiary care facilities. As cardiovascular and respiratory diseases remain leading causes of mortality globally, demand for advanced life-support technologies is expected to remain steady. Expansion of Advanced Critical Care Infrastructure Healthcare systems worldwide are strengthening ICU capabilities and investing in specialized cardiac centers. The integration of ECMO programs into hospital protocols enhances treatment outcomes for high-risk patients. This infrastructure development directly supports market expansion, particularly in emerging economies upgrading their healthcare systems. Technological Advancements and Portability Improvements Innovations in compact systems, enhanced membrane durability, and user-friendly controllers have improved clinical usability and patient safety. Portable ECMO devices facilitate intra-hospital transport and emergency applications, broadening the scope of use beyond traditional ICU settings and improving operational efficiency. High Procedural Costs and Skilled Workforce Requirements Despite clinical benefits, ECMO therapy involves substantial capital investment, operational costs, and the need for specialized perfusion teams. The limited availability of trained professionals and reimbursement constraints in certain regions may restrict broader adoption, particularly in cost-sensitive healthcare markets. Clinical Risk and Complication Management Complications such as bleeding, infection, and thrombosis remain inherent challenges. Continuous monitoring and improved anticoagulation strategies are critical to mitigating risks, making safety enhancements a central focus for manufacturers and care providers. Opportunity Mapping Based on Market Trends Growing Adoption in Emerging Economies As healthcare spending increases in Asia Pacific and parts of LAMEA, investment in advanced life-support systems presents untapped growth potential. Strategic partnerships and localized manufacturing could enhance accessibility and affordability. Integration with Digital Monitoring and AI Analytics The incorporation of real-time monitoring systems and predictive analytics into ECMO controllers can enhance patient management and reduce complications. Digital integration offers opportunities for differentiated product positioning and value-based healthcare models. Expansion of ECMO Centers of Excellence The establishment of specialized ECMO programs within hospitals creates recurring equipment demand and long-term service contracts. Training partnerships and clinical support services represent additional revenue streams for device manufacturers. Bridge-to-Transplant and ECPR Applications Increasing utilization of ECMO as a bridge-to-heart or lung transplant and in extracorporeal cardiopulmonary resuscitation (ECPR) scenarios broadens its clinical relevance. These high-acuity applications reinforce the strategic importance of ECMO in advanced cardiac care pathways. Key Market Segments By Component: - Pumps - Oxygenator - Controllers By Modality: - VA - VV - AV By Patient Type: - Adult Patients - Pediatric Patients - Neonatal Patients By Application: - Cardiac Support - Respiratory Support - Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Bridge to Transplant Value-Creating Segments and Growth Pockets The Oxygenator segment currently dominates revenue generation due to its recurring replacement demand and central role in ECMO therapy. While Pumps and Controllers are essential capital components, oxygenators drive consistent procedural revenue streams. Among modalities, Veno-Arterial (VA) ECMO leads in cardiac support applications, whereas Veno-Venous (VV) ECMO is expected to witness steady growth owing to increasing respiratory failure cases. AV modality remains comparatively niche but serves specific clinical scenarios. Adult patients account for the majority of ECMO utilization, reflecting higher incidence rates of cardiopulmonary conditions in this demographic. However, Neonatal and Pediatric segments represent specialized high-value niches, supported by advancements in miniaturized systems tailored for smaller patients. From an application perspective, Cardiac Support remains dominant, while Extracorporeal Cardiopulmonary Resuscitation (ECPR) and Bridge-to-Transplant applications are anticipated to grow steadily as transplant programs and emergency cardiac interventions expand globally. Regional Market Assessment North America North America leads the global ECMO market due to advanced healthcare infrastructure, strong reimbursement frameworks, and established ECMO centers of excellence. High adoption rates in specialized cardiac hospitals support sustained demand. Europe Europe demonstrates stable growth driven by universal healthcare systems and increasing focus on advanced critical care. Collaborative clinical research and cross-border medical standards further support ECMO integration in tertiary care centers. Asia Pacific Asia Pacific is expected to exhibit notable growth, supported by rising healthcare investments, expanding hospital networks, and increasing awareness of advanced life-support therapies. Large patient populations create scalable demand opportunities. LAMEA The LAMEA region shows gradual adoption, particularly in the Middle East where healthcare modernization initiatives are accelerating. In Latin America and parts of Africa, growth is moderated by budgetary constraints but supported by improving tertiary care infrastructure. Recent Developments - April 2024: A leading medical device manufacturer launched a compact ECMO system designed for improved portability and enhanced patient safety, addressing growing demand for flexible critical care solutions. - November 2023: A tertiary hospital network expanded its ECMO program with specialized training initiatives, reinforcing the importance of skilled workforce development in market growth. - January 2024: A medical technology firm introduced an advanced oxygenator with extended membrane durability, reducing replacement frequency and enhancing cost efficiency for healthcare providers. Critical Business Questions Addressed - What is the long-term revenue outlook of the global ECMO machine market through 2035- The report evaluates steady mid-single-digit growth driven by rising cardiopulmonary disease prevalence and healthcare infrastructure investments. - Which components and modalities generate the highest value- Oxygenators and VA modality dominate revenue contribution, while specialized applications create incremental growth opportunities. - How should manufacturers address cost and workforce challenges- Strategic investments in training partnerships and modular system design can enhance accessibility and operational efficiency. - Which patient segments offer future expansion potential- While adults lead demand, neonatal and pediatric segments represent specialized growth niches supported by technological advancements. - How does regional healthcare infrastructure impact adoption- Market expansion is closely linked to ICU capacity, reimbursement systems, and national healthcare modernization strategies. Beyond the Forecast The ECMO machine market reflects a critical intersection between advanced technology and life-saving care. As healthcare systems emphasize resilience and high-acuity treatment capabilities, ECMO will remain central to specialized cardiac and respiratory support pathways. Manufacturers that prioritize innovation in safety, portability, and digital integration will strengthen their competitive positioning. Over the long term, the evolution of ECMO programs into standardized components of critical care infrastructure will define sustainable market expansion. 目次Table of ContentsChapter 1. Global ECMO Machine Market Report Scope & Methodology 1.1. Market Definition 1.2. Market Segmentation 1.3. Research Assumption 1.3.1. Inclusion & Exclusion 1.3.2. Limitations 1.4. Research Objective 1.5. Research Methodology 1.5.1. Forecast Model 1.5.2. Desk Research 1.5.3. Top Down and Bottom-Up Approach 1.6. Research Attributes 1.7. Years Considered for the Study Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Strategic Insights 2.3. Top Findings 2.4. CEO/CXO Standpoint 2.5. ESG Analysis Chapter 3. Global ECMO Machine Market Forces Analysis 3.1. Market Forces Shaping The Global ECMO Machine Market (2024-2035) 3.2. Drivers 3.2.1. Rising Incidence of Cardiopulmonary Disorders 3.2.2. Expansion of Advanced Critical Care Infrastructure 3.2.3. Technological Advancements and Portability Improvements 3.3. Restraints 3.3.1. High Procedural Costs and Skilled Workforce Requirements 3.3.2. Clinical Risk and Complication Management 3.4. Opportunities 3.4.1. Growing Adoption in Emerging Economies 3.4.2. Integration with Digital Monitoring and AI Analytics Chapter 4. Global ECMO Machine Industry Analysis 4.1. Porter’s 5 Forces Model 4.2. Porter’s 5 Force Forecast Model (2024-2035) 4.3. PESTEL Analysis 4.4. Macroeconomic Industry Trends 4.4.1. Parent Market Trends 4.4.2. GDP Trends & Forecasts 4.5. Value Chain Analysis 4.6. Top Investment Trends & Forecasts 4.7. Top Winning Strategies (2025) 4.8. Market Share Analysis (2024-2025) 4.9. Pricing Analysis 4.10. Investment & Funding Scenario 4.11. Impact of Geopolitical & Trade Policy Volatility on the Market Chapter 5. AI Adoption Trends and Market Influence 5.1. AI Readiness Index 5.2. Key Emerging Technologies 5.3. Patent Analysis 5.4. Top Case Studies Chapter 6. Global ECMO Machine Market Size & Forecasts by Component 2025-2035 6.1. Market Overview 6.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 6.3. Pumps 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.3.2. Market size analysis, by region, 2025-2035 6.4. Oxygenator 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.4.2. Market size analysis, by region, 2025-2035 6.5. Controllers 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.5.2. Market size analysis, by region, 2025-2035 Chapter 7. Global ECMO Machine Market Size & Forecasts by Modality 2025-2035 7.1. Market Overview 7.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 7.3. VA 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.3.2. Market size analysis, by region, 2025-2035 7.4. VV 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.4.2. Market size analysis, by region, 2025-2035 7.5. AV 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.5.2. Market size analysis, by region, 2025-2035 Chapter 8. Global ECMO Machine Market Size & Forecasts by Patient Type 2025-2035 8.1. Market Overview 8.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 8.3. Adult Patients 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.3.2. Market size analysis, by region, 2025-2035 8.4. Pediatric Patients 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.4.2. Market size analysis, by region, 2025-2035 8.5. Neonatal Patients 8.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.5.2. Market size analysis, by region, 2025-2035 Chapter 9. Global ECMO Machine Market Size & Forecasts by Application 2025-2035 9.1. Market Overview 9.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 9.3. Cardiac Support 9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.3.2. Market size analysis, by region, 2025-2035 9.4. Respiratory Support 9.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.4.2. Market size analysis, by region, 2025-2035 9.5. Respiratory Support 9.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.5.2. Market size analysis, by region, 2025-2035 9.6. Bridge to Transplant 9.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.6.2. Market size analysis, by region, 2025-2035 Chapter 10. Global ECMO Machine Market Size & Forecasts by Region 2025–2035 10.1. Growth ECMO Machine Market, Regional Market Snapshot 10.2. Top Leading & Emerging Countries 10.3. North America ECMO Machine Market 10.3.1. U.S. ECMO Machine Market 10.3.1.1. Component breakdown size & forecasts, 2025-2035 10.3.1.2. Modality breakdown size & forecasts, 2025-2035 10.3.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.3.1.4. Application breakdown size & forecasts, 2025-2035 10.3.2. Canada ECMO Machine Market 10.3.2.1. Component breakdown size & forecasts, 2025-2035 10.3.2.2. Modality breakdown size & forecasts, 2025-2035 10.3.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.3.2.4. Application breakdown size & forecasts, 2025-2035 10.4. Europe ECMO Machine Market 10.4.1. UK ECMO Machine Market 10.4.1.1. Component breakdown size & forecasts, 2025-2035 10.4.1.2. Modality breakdown size & forecasts, 2025-2035 10.4.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.1.4. Application breakdown size & forecasts, 2025-2035 10.4.2. Germany ECMO Machine Market 10.4.2.1. Component breakdown size & forecasts, 2025-2035 10.4.2.2. Modality breakdown size & forecasts, 2025-2035 10.4.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.2.4. Application breakdown size & forecasts, 2025-2035 10.4.3. France ECMO Machine Market 10.4.3.1. Component breakdown size & forecasts, 2025-2035 10.4.3.2. Modality breakdown size & forecasts, 2025-2035 10.4.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.3.4. Application breakdown size & forecasts, 2025-2035 10.4.4. Spain ECMO Machine Market 10.4.4.1. Component breakdown size & forecasts, 2025-2035 10.4.4.2. Modality breakdown size & forecasts, 2025-2035 10.4.4.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.4.4. Application breakdown size & forecasts, 2025-2035 10.4.5. Italy ECMO Machine Market 10.4.5.1. Component breakdown size & forecasts, 2025-2035 10.4.5.2. Modality breakdown size & forecasts, 2025-2035 10.4.5.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.5.4. Application breakdown size & forecasts, 2025-2035 10.4.6. Rest of Europe ECMO Machine Market 10.4.6.1. Component breakdown size & forecasts, 2025-2035 10.4.6.2. Modality breakdown size & forecasts, 2025-2035 10.4.6.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.6.4. Application breakdown size & forecasts, 2025-2035 10.5. Asia Pacific ECMO Machine Market 10.5.1. China ECMO Machine Market 10.5.1.1. Component breakdown size & forecasts, 2025-2035 10.5.1.2. Modality breakdown size & forecasts, 2025-2035 10.5.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.1.4. Application breakdown size & forecasts, 2025-2035 10.5.2. India ECMO Machine Market 10.5.2.1. Component breakdown size & forecasts, 2025-2035 10.5.2.2. Modality breakdown size & forecasts, 2025-2035 10.5.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.2.4. Application breakdown size & forecasts, 2025-2035 10.5.3. Japan ECMO Machine Market 10.5.3.1. Component breakdown size & forecasts, 2025-2035 10.5.3.2. Modality breakdown size & forecasts, 2025-2035 10.5.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.3.4. Application breakdown size & forecasts, 2025-2035 10.5.4. Australia ECMO Machine Market 10.5.4.1. Component breakdown size & forecasts, 2025-2035 10.5.4.2. Modality breakdown size & forecasts, 2025-2035 10.5.4.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.4.4. Application breakdown size & forecasts, 2025-2035 10.5.5. South Korea ECMO Machine Market 10.5.5.1. Component breakdown size & forecasts, 2025-2035 10.5.5.2. Modality breakdown size & forecasts, 2025-2035 10.5.5.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.5.4. Application breakdown size & forecasts, 2025-2035 10.5.6. Rest of APAC ECMO Machine Market 10.5.6.1. Component breakdown size & forecasts, 2025-2035 10.5.6.2. Modality breakdown size & forecasts, 2025-2035 10.5.6.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.6.4. Application breakdown size & forecasts, 2025-2035 10.6. Latin America ECMO Machine Market 10.6.1. Brazil ECMO Machine Market 10.6.1.1. Component breakdown size & forecasts, 2025-2035 10.6.1.2. Modality breakdown size & forecasts, 2025-2035 10.6.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.6.1.4. Application breakdown size & forecasts, 2025-2035 10.6.2. Mexico ECMO Machine Market 10.6.2.1. Component breakdown size & forecasts, 2025-2035 10.6.2.2. Modality breakdown size & forecasts, 2025-2035 10.6.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.6.2.4. Application breakdown size & forecasts, 2025-2035 10.7. Middle East and Africa ECMO Machine Market 10.7.1. UAE ECMO Machine Market 10.7.1.1. Component breakdown size & forecasts, 2025-2035 10.7.1.2. Modality breakdown size & forecasts, 2025-2035 10.7.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.1.4. Application breakdown size & forecasts, 2025-2035 10.7.2. Saudi Arabia (KSA) ECMO Machine Market 10.7.2.1. Component breakdown size & forecasts, 2025-2035 10.7.2.2. Modality breakdown size & forecasts, 2025-2035 10.7.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.2.4. Application breakdown size & forecasts, 2025-2035 10.7.3. South Africa ECMO Machine Market 10.7.3.1. Component breakdown size & forecasts, 2025-2035 10.7.3.2. Modality breakdown size & forecasts, 2025-2035 10.7.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.3.4. Application breakdown size & forecasts, 2025-2035 Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Medtronic Plc 11.2.1. Company Overview 11.2.2. Key Executives 11.2.3. Company Snapshot 11.2.4. Financial Performance (Subject to Data Availability) 11.2.5. Product/Services Port 11.2.6. Recent Development 11.2.7. Market Strategies 11.2.8. SWOT Analysis 11.3. Maquet Holding 11.4. Microport Scientific Corporation 11.5. Terumo Cardiovascular System Corporation 11.6. Medos Medizintechnik 11.7. Nipro Medical Corporation 11.8. LivaNova PLC 11.9. CytoSorbents Corporation 11.10. EUROSETS S.R.L 図表リストList of TablesTable 1. Global ECMO Machine Market, Report Scope Table 2. Global ECMO Machine Market Estimates & Forecasts By Region 2024–2035 Table 3. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 4. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 5. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 6. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 7. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 8. U.S. ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 9. Canada ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 10. UK ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 11. Germany ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 12. France ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 13. Spain ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 14. Italy ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 15. Rest Of Europe ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 16. China ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 17. India ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 18. Japan ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 19. Australia ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 20. South Korea ECMO Machine Market Estimates & Forecasts, 2024–2035 ………….
SummaryMarket Definition, Recent Developments & Industry TrendsExtracorporeal Membrane Oxygenation (ECMO) machines are advanced life-support systems designed to provide prolonged cardiac and respiratory assistance to patients whose heart and lungs are unable to function adequately. The system works by circulating blood through an external artificial lung (oxygenator) and pump, facilitating gas exchange and hemodynamic support before returning it to the patientfs body. The ECMO ecosystem comprises device manufacturers, critical care units, perfusionists, cardiac surgeons, and tertiary care hospitals, primarily operating within intensive care and specialized cardiac centers. The market has evolved significantly over the past decade, driven by technological advancements in miniaturized pumps, biocompatible oxygenators, and portable ECMO systems. Increased clinical adoption during global respiratory crises and rising cases of cardiopulmonary disorders have expanded the utilization landscape. As healthcare systems invest in advanced critical care infrastructure, ECMO is increasingly positioned as both a rescue therapy and a bridge-to-transplant solution. Looking ahead to 2035, integration of digital monitoring systems, improved safety profiles, and expansion into emerging healthcare markets are expected to shape the competitive and technological trajectory of the ECMO machine industry. Key Findings of the Report - Market Size (2024): USD 0.32 billion - Estimated Market Size (2035): USD 0.58 billion - CAGR (2025-2035): 5.50% - Leading Regional Market: North America - Leading Segment: Oxygenator under Component Market Determinants Rising Incidence of Cardiopulmonary Disorders The growing prevalence of acute respiratory distress syndrome (ARDS), heart failure, and cardiogenic shock is a primary growth driver. ECMO machines provide life-saving support in critical cases, increasing their adoption in tertiary care facilities. As cardiovascular and respiratory diseases remain leading causes of mortality globally, demand for advanced life-support technologies is expected to remain steady. Expansion of Advanced Critical Care Infrastructure Healthcare systems worldwide are strengthening ICU capabilities and investing in specialized cardiac centers. The integration of ECMO programs into hospital protocols enhances treatment outcomes for high-risk patients. This infrastructure development directly supports market expansion, particularly in emerging economies upgrading their healthcare systems. Technological Advancements and Portability Improvements Innovations in compact systems, enhanced membrane durability, and user-friendly controllers have improved clinical usability and patient safety. Portable ECMO devices facilitate intra-hospital transport and emergency applications, broadening the scope of use beyond traditional ICU settings and improving operational efficiency. High Procedural Costs and Skilled Workforce Requirements Despite clinical benefits, ECMO therapy involves substantial capital investment, operational costs, and the need for specialized perfusion teams. The limited availability of trained professionals and reimbursement constraints in certain regions may restrict broader adoption, particularly in cost-sensitive healthcare markets. Clinical Risk and Complication Management Complications such as bleeding, infection, and thrombosis remain inherent challenges. Continuous monitoring and improved anticoagulation strategies are critical to mitigating risks, making safety enhancements a central focus for manufacturers and care providers. Opportunity Mapping Based on Market Trends Growing Adoption in Emerging Economies As healthcare spending increases in Asia Pacific and parts of LAMEA, investment in advanced life-support systems presents untapped growth potential. Strategic partnerships and localized manufacturing could enhance accessibility and affordability. Integration with Digital Monitoring and AI Analytics The incorporation of real-time monitoring systems and predictive analytics into ECMO controllers can enhance patient management and reduce complications. Digital integration offers opportunities for differentiated product positioning and value-based healthcare models. Expansion of ECMO Centers of Excellence The establishment of specialized ECMO programs within hospitals creates recurring equipment demand and long-term service contracts. Training partnerships and clinical support services represent additional revenue streams for device manufacturers. Bridge-to-Transplant and ECPR Applications Increasing utilization of ECMO as a bridge-to-heart or lung transplant and in extracorporeal cardiopulmonary resuscitation (ECPR) scenarios broadens its clinical relevance. These high-acuity applications reinforce the strategic importance of ECMO in advanced cardiac care pathways. Key Market Segments By Component: - Pumps - Oxygenator - Controllers By Modality: - VA - VV - AV By Patient Type: - Adult Patients - Pediatric Patients - Neonatal Patients By Application: - Cardiac Support - Respiratory Support - Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Bridge to Transplant Value-Creating Segments and Growth Pockets The Oxygenator segment currently dominates revenue generation due to its recurring replacement demand and central role in ECMO therapy. While Pumps and Controllers are essential capital components, oxygenators drive consistent procedural revenue streams. Among modalities, Veno-Arterial (VA) ECMO leads in cardiac support applications, whereas Veno-Venous (VV) ECMO is expected to witness steady growth owing to increasing respiratory failure cases. AV modality remains comparatively niche but serves specific clinical scenarios. Adult patients account for the majority of ECMO utilization, reflecting higher incidence rates of cardiopulmonary conditions in this demographic. However, Neonatal and Pediatric segments represent specialized high-value niches, supported by advancements in miniaturized systems tailored for smaller patients. From an application perspective, Cardiac Support remains dominant, while Extracorporeal Cardiopulmonary Resuscitation (ECPR) and Bridge-to-Transplant applications are anticipated to grow steadily as transplant programs and emergency cardiac interventions expand globally. Regional Market Assessment North America North America leads the global ECMO market due to advanced healthcare infrastructure, strong reimbursement frameworks, and established ECMO centers of excellence. High adoption rates in specialized cardiac hospitals support sustained demand. Europe Europe demonstrates stable growth driven by universal healthcare systems and increasing focus on advanced critical care. Collaborative clinical research and cross-border medical standards further support ECMO integration in tertiary care centers. Asia Pacific Asia Pacific is expected to exhibit notable growth, supported by rising healthcare investments, expanding hospital networks, and increasing awareness of advanced life-support therapies. Large patient populations create scalable demand opportunities. LAMEA The LAMEA region shows gradual adoption, particularly in the Middle East where healthcare modernization initiatives are accelerating. In Latin America and parts of Africa, growth is moderated by budgetary constraints but supported by improving tertiary care infrastructure. Recent Developments - April 2024: A leading medical device manufacturer launched a compact ECMO system designed for improved portability and enhanced patient safety, addressing growing demand for flexible critical care solutions. - November 2023: A tertiary hospital network expanded its ECMO program with specialized training initiatives, reinforcing the importance of skilled workforce development in market growth. - January 2024: A medical technology firm introduced an advanced oxygenator with extended membrane durability, reducing replacement frequency and enhancing cost efficiency for healthcare providers. Critical Business Questions Addressed - What is the long-term revenue outlook of the global ECMO machine market through 2035- The report evaluates steady mid-single-digit growth driven by rising cardiopulmonary disease prevalence and healthcare infrastructure investments. - Which components and modalities generate the highest value- Oxygenators and VA modality dominate revenue contribution, while specialized applications create incremental growth opportunities. - How should manufacturers address cost and workforce challenges- Strategic investments in training partnerships and modular system design can enhance accessibility and operational efficiency. - Which patient segments offer future expansion potential- While adults lead demand, neonatal and pediatric segments represent specialized growth niches supported by technological advancements. - How does regional healthcare infrastructure impact adoption- Market expansion is closely linked to ICU capacity, reimbursement systems, and national healthcare modernization strategies. Beyond the Forecast The ECMO machine market reflects a critical intersection between advanced technology and life-saving care. As healthcare systems emphasize resilience and high-acuity treatment capabilities, ECMO will remain central to specialized cardiac and respiratory support pathways. Manufacturers that prioritize innovation in safety, portability, and digital integration will strengthen their competitive positioning. Over the long term, the evolution of ECMO programs into standardized components of critical care infrastructure will define sustainable market expansion. Table of ContentsTable of ContentsChapter 1. Global ECMO Machine Market Report Scope & Methodology 1.1. Market Definition 1.2. Market Segmentation 1.3. Research Assumption 1.3.1. Inclusion & Exclusion 1.3.2. Limitations 1.4. Research Objective 1.5. Research Methodology 1.5.1. Forecast Model 1.5.2. Desk Research 1.5.3. Top Down and Bottom-Up Approach 1.6. Research Attributes 1.7. Years Considered for the Study Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Strategic Insights 2.3. Top Findings 2.4. CEO/CXO Standpoint 2.5. ESG Analysis Chapter 3. Global ECMO Machine Market Forces Analysis 3.1. Market Forces Shaping The Global ECMO Machine Market (2024-2035) 3.2. Drivers 3.2.1. Rising Incidence of Cardiopulmonary Disorders 3.2.2. Expansion of Advanced Critical Care Infrastructure 3.2.3. Technological Advancements and Portability Improvements 3.3. Restraints 3.3.1. High Procedural Costs and Skilled Workforce Requirements 3.3.2. Clinical Risk and Complication Management 3.4. Opportunities 3.4.1. Growing Adoption in Emerging Economies 3.4.2. Integration with Digital Monitoring and AI Analytics Chapter 4. Global ECMO Machine Industry Analysis 4.1. Porter’s 5 Forces Model 4.2. Porter’s 5 Force Forecast Model (2024-2035) 4.3. PESTEL Analysis 4.4. Macroeconomic Industry Trends 4.4.1. Parent Market Trends 4.4.2. GDP Trends & Forecasts 4.5. Value Chain Analysis 4.6. Top Investment Trends & Forecasts 4.7. Top Winning Strategies (2025) 4.8. Market Share Analysis (2024-2025) 4.9. Pricing Analysis 4.10. Investment & Funding Scenario 4.11. Impact of Geopolitical & Trade Policy Volatility on the Market Chapter 5. AI Adoption Trends and Market Influence 5.1. AI Readiness Index 5.2. Key Emerging Technologies 5.3. Patent Analysis 5.4. Top Case Studies Chapter 6. Global ECMO Machine Market Size & Forecasts by Component 2025-2035 6.1. Market Overview 6.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 6.3. Pumps 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.3.2. Market size analysis, by region, 2025-2035 6.4. Oxygenator 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.4.2. Market size analysis, by region, 2025-2035 6.5. Controllers 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.5.2. Market size analysis, by region, 2025-2035 Chapter 7. Global ECMO Machine Market Size & Forecasts by Modality 2025-2035 7.1. Market Overview 7.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 7.3. VA 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.3.2. Market size analysis, by region, 2025-2035 7.4. VV 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.4.2. Market size analysis, by region, 2025-2035 7.5. AV 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 7.5.2. Market size analysis, by region, 2025-2035 Chapter 8. Global ECMO Machine Market Size & Forecasts by Patient Type 2025-2035 8.1. Market Overview 8.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 8.3. Adult Patients 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.3.2. Market size analysis, by region, 2025-2035 8.4. Pediatric Patients 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.4.2. Market size analysis, by region, 2025-2035 8.5. Neonatal Patients 8.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 8.5.2. Market size analysis, by region, 2025-2035 Chapter 9. Global ECMO Machine Market Size & Forecasts by Application 2025-2035 9.1. Market Overview 9.2. Global ECMO Machine Market Performance - Potential Analysis (2025) 9.3. Cardiac Support 9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.3.2. Market size analysis, by region, 2025-2035 9.4. Respiratory Support 9.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.4.2. Market size analysis, by region, 2025-2035 9.5. Respiratory Support 9.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.5.2. Market size analysis, by region, 2025-2035 9.6. Bridge to Transplant 9.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 9.6.2. Market size analysis, by region, 2025-2035 Chapter 10. Global ECMO Machine Market Size & Forecasts by Region 2025–2035 10.1. Growth ECMO Machine Market, Regional Market Snapshot 10.2. Top Leading & Emerging Countries 10.3. North America ECMO Machine Market 10.3.1. U.S. ECMO Machine Market 10.3.1.1. Component breakdown size & forecasts, 2025-2035 10.3.1.2. Modality breakdown size & forecasts, 2025-2035 10.3.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.3.1.4. Application breakdown size & forecasts, 2025-2035 10.3.2. Canada ECMO Machine Market 10.3.2.1. Component breakdown size & forecasts, 2025-2035 10.3.2.2. Modality breakdown size & forecasts, 2025-2035 10.3.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.3.2.4. Application breakdown size & forecasts, 2025-2035 10.4. Europe ECMO Machine Market 10.4.1. UK ECMO Machine Market 10.4.1.1. Component breakdown size & forecasts, 2025-2035 10.4.1.2. Modality breakdown size & forecasts, 2025-2035 10.4.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.1.4. Application breakdown size & forecasts, 2025-2035 10.4.2. Germany ECMO Machine Market 10.4.2.1. Component breakdown size & forecasts, 2025-2035 10.4.2.2. Modality breakdown size & forecasts, 2025-2035 10.4.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.2.4. Application breakdown size & forecasts, 2025-2035 10.4.3. France ECMO Machine Market 10.4.3.1. Component breakdown size & forecasts, 2025-2035 10.4.3.2. Modality breakdown size & forecasts, 2025-2035 10.4.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.3.4. Application breakdown size & forecasts, 2025-2035 10.4.4. Spain ECMO Machine Market 10.4.4.1. Component breakdown size & forecasts, 2025-2035 10.4.4.2. Modality breakdown size & forecasts, 2025-2035 10.4.4.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.4.4. Application breakdown size & forecasts, 2025-2035 10.4.5. Italy ECMO Machine Market 10.4.5.1. Component breakdown size & forecasts, 2025-2035 10.4.5.2. Modality breakdown size & forecasts, 2025-2035 10.4.5.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.5.4. Application breakdown size & forecasts, 2025-2035 10.4.6. Rest of Europe ECMO Machine Market 10.4.6.1. Component breakdown size & forecasts, 2025-2035 10.4.6.2. Modality breakdown size & forecasts, 2025-2035 10.4.6.3. Patient Type breakdown size & forecasts, 2025-2035 10.4.6.4. Application breakdown size & forecasts, 2025-2035 10.5. Asia Pacific ECMO Machine Market 10.5.1. China ECMO Machine Market 10.5.1.1. Component breakdown size & forecasts, 2025-2035 10.5.1.2. Modality breakdown size & forecasts, 2025-2035 10.5.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.1.4. Application breakdown size & forecasts, 2025-2035 10.5.2. India ECMO Machine Market 10.5.2.1. Component breakdown size & forecasts, 2025-2035 10.5.2.2. Modality breakdown size & forecasts, 2025-2035 10.5.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.2.4. Application breakdown size & forecasts, 2025-2035 10.5.3. Japan ECMO Machine Market 10.5.3.1. Component breakdown size & forecasts, 2025-2035 10.5.3.2. Modality breakdown size & forecasts, 2025-2035 10.5.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.3.4. Application breakdown size & forecasts, 2025-2035 10.5.4. Australia ECMO Machine Market 10.5.4.1. Component breakdown size & forecasts, 2025-2035 10.5.4.2. Modality breakdown size & forecasts, 2025-2035 10.5.4.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.4.4. Application breakdown size & forecasts, 2025-2035 10.5.5. South Korea ECMO Machine Market 10.5.5.1. Component breakdown size & forecasts, 2025-2035 10.5.5.2. Modality breakdown size & forecasts, 2025-2035 10.5.5.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.5.4. Application breakdown size & forecasts, 2025-2035 10.5.6. Rest of APAC ECMO Machine Market 10.5.6.1. Component breakdown size & forecasts, 2025-2035 10.5.6.2. Modality breakdown size & forecasts, 2025-2035 10.5.6.3. Patient Type breakdown size & forecasts, 2025-2035 10.5.6.4. Application breakdown size & forecasts, 2025-2035 10.6. Latin America ECMO Machine Market 10.6.1. Brazil ECMO Machine Market 10.6.1.1. Component breakdown size & forecasts, 2025-2035 10.6.1.2. Modality breakdown size & forecasts, 2025-2035 10.6.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.6.1.4. Application breakdown size & forecasts, 2025-2035 10.6.2. Mexico ECMO Machine Market 10.6.2.1. Component breakdown size & forecasts, 2025-2035 10.6.2.2. Modality breakdown size & forecasts, 2025-2035 10.6.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.6.2.4. Application breakdown size & forecasts, 2025-2035 10.7. Middle East and Africa ECMO Machine Market 10.7.1. UAE ECMO Machine Market 10.7.1.1. Component breakdown size & forecasts, 2025-2035 10.7.1.2. Modality breakdown size & forecasts, 2025-2035 10.7.1.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.1.4. Application breakdown size & forecasts, 2025-2035 10.7.2. Saudi Arabia (KSA) ECMO Machine Market 10.7.2.1. Component breakdown size & forecasts, 2025-2035 10.7.2.2. Modality breakdown size & forecasts, 2025-2035 10.7.2.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.2.4. Application breakdown size & forecasts, 2025-2035 10.7.3. South Africa ECMO Machine Market 10.7.3.1. Component breakdown size & forecasts, 2025-2035 10.7.3.2. Modality breakdown size & forecasts, 2025-2035 10.7.3.3. Patient Type breakdown size & forecasts, 2025-2035 10.7.3.4. Application breakdown size & forecasts, 2025-2035 Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Medtronic Plc 11.2.1. Company Overview 11.2.2. Key Executives 11.2.3. Company Snapshot 11.2.4. Financial Performance (Subject to Data Availability) 11.2.5. Product/Services Port 11.2.6. Recent Development 11.2.7. Market Strategies 11.2.8. SWOT Analysis 11.3. Maquet Holding 11.4. Microport Scientific Corporation 11.5. Terumo Cardiovascular System Corporation 11.6. Medos Medizintechnik 11.7. Nipro Medical Corporation 11.8. LivaNova PLC 11.9. CytoSorbents Corporation 11.10. EUROSETS S.R.L List of Tables/GraphsList of TablesTable 1. Global ECMO Machine Market, Report Scope Table 2. Global ECMO Machine Market Estimates & Forecasts By Region 2024–2035 Table 3. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 4. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 5. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 6. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 7. Global ECMO Machine Market Estimates & Forecasts By Segment 2024–2035 Table 8. U.S. ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 9. Canada ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 10. UK ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 11. Germany ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 12. France ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 13. Spain ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 14. Italy ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 15. Rest Of Europe ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 16. China ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 17. India ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 18. Japan ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 19. Australia ECMO Machine Market Estimates & Forecasts, 2024–2035 Table 20. South Korea ECMO Machine Market Estimates & Forecasts, 2024–2035 ………….
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Bizwit Research & Consulting LLP社の 医療・ライフサイエンス分野 での最新刊レポート
本レポートと同じKEY WORD(pumps)の最新刊レポートよくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|